Hello AAPS Community Members –
For the upcoming NAber working group next week on Tuesday, April 15th, we are excited to share that Maria Jadhav will share a presentation titled "Navigating the Complexity of Neutralizing Antibody (nAb) Evaluation for Multi-Domain Biotherapeutics" fresh off the presentation at WRIB. Dr. Jadhav is a Director, GCP Bioanalytics Team Lead Cambridge at Novartis.
Tuesday, April 15th, at 12:00 EST Agenda
- Dr. Maria Jadhav, Novartis - Navigating the Complexity of Neutralizing Antibody (nAb) Evaluation for Multi-Domain Biotherapeutics
- AOB
For anyone considering joining the NAber Working Group or who would be interested in the specific April 15th discussion, please feel free to reach out and contact @Lynn Kamen @Weifeng Xu or @Andrew Asberry to learn more about the NAber Working Group or for a link to attend this session.
------------------------------
Andrew Asberry
Director, Oncology Bioanalytical Strategy Lead
AstraZeneca, Plc
Gaithersburg MD
[email protected]Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
------------------------------